title: Hemostasis of left atrial appendage bleed with lariat device.
abstract: New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires both trans-septal puncture and epicardial access. However it requires no anticoagulation after the procedure. Here we describe a case of effusion and tamponade during a Lariat procedure with successful completion of the case and resolution of the effusion.
authors.affiliation: NYU Langone Medical Center, United States.
authors.forename: Amena
authors.initials: A
authors.lastname: Hussain
authors.affiliation: NYU Langone Medical Center, United States.
authors.forename: Muhamed
authors.initials: M
authors.lastname: Saric
authors.affiliation: NYU Langone Medical Center, United States.
authors.forename: Scott
authors.initials: S
authors.lastname: Bernstein
authors.affiliation: NYU Langone Medical Center, United States.
authors.forename: Douglas
authors.initials: D
authors.lastname: Holmes
authors.affiliation: NYU Langone Medical Center, United States.
authors.forename: Larry
authors.initials: L
authors.lastname: Chinitz
keywords: Lariat Device; Left Atrial Appendage